glp-1 agonists and retained gastric contents at endoscopy Receptor Gastrointestinal Endoscopy: A Narrative Review of Risks, Management Strategies, and the Need for Clinical Consensus Gastrointestinal effects of GLP-1 receptor

Among the marketed large molecule injectable GLP-1 agonists, semaglutide, apart from weight-loss, is being studied for kidney disease and tirzepatide (a dual GLP-1 and GIP receptor agonist) is being evaluated for sleep apnea in Ph 3 clinical trials

If you took Januvia, Victoza, Janumet and / or Byetta had side effects & developed pancreatic cancer - contact a diabetes medication lawyer.

Society guidelines have left clinicians with some questionable recommendations

Vegetarian capsules with chlorophyll, no artificial additives

Reduced risk of side effects

Spontaneous reports do not represent unique exposed individuals and were not pooled with participant counts